Peter Liljeström

1951 -

гражданство: Швеция

род занятий: исследователь

Серия

There is nothing here

Создать новую серию

Произведения

There is nothing here

Создать новое произведение

Статьи 57

Дата

Заголовок

Авторы

2019-03-21

Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV

Carmen E Gómez, Mariano Esteban, Juan García-Arriaza, Carlos Oscar Sanchez Sorzano, Peter Liljeström, Karl Ljungberg
2018-03-07

Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins.

Mariano Esteban, Juan García-Arriaza, Lucas Sánchez-Sampedro, Peter Liljeström, Adrián Lázaro-Frías, Karl Ljungberg
2018-07-26

Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens

Hans W Nijman, Peter Liljeström, Toos Daemen
2017-03-23

Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus

Pierre Roques, Nathalie Dereuddre-Bosquet, Mariano Esteban, Andres Merits, Beate M. Kümmerer, David Hallengärd, Juan García-Arriaza, Peter Liljeström, Karl Ljungberg, Roger Le Grand
2015-02-02

Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen

Karl Ljungberg, Mariano Esteban, Peter Liljeström
2014-11

Prime-boost immunization strategies against Chikungunya virus

Mariano Esteban, John Fazakerley, Valeria Lulla, Pierre Roques, Andres Merits, Lisa Ng, Fok-Moon Lum, Beate M. Kümmerer, David Hallengärd, Aleksei Lulla, Juan García-Arriaza, Peter Liljeström, Roger Le Grand
2014-08-13

Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations

Karl Ljungberg, Juan García-Arriaza, Andres Merits, Mariano Esteban, Peter Liljeström, Linda Kostic
2014-07-10

A 6K-deletion variant of salmonid alphavirus is non-viable but can be rescued through RNA recombination

Peter Liljeström
2014-01-08

A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection

Juan García-Arriaza, Peter Liljeström, Mariano Esteban, Victoria Cepeda, Carlos Oscar Sanchez Sorzano
2014-10-01

Self-replicating alphavirus RNA vaccines

Karl Ljungberg, Peter Liljeström
2014-11-13

Modification of a salmonid alphavirus replicon vector for enhanced expression of heterologous antigens

Peter Liljeström
2014-01-01

Intradermal electroporation of RNA

Karl Ljungberg, Peter Liljeström
2012-01-04

Intradermal electroporation of naked replicon RNA elicits strong immune responses

Karl Ljungberg, Peter Liljeström
2012-05-11

De-novo transcriptome sequencing of a normalized cDNA pool from influenza infected ferrets

Jeremy V Camp, Colleen B. Jonsson, Peter Liljeström
2011-01-24

Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines

Peter Liljeström
2011-09-09

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

Felipe García, Juan García-Arriaza, Vicens Diaz-Brito, José Alcamí, Mª Ángeles Muñoz-Fernández, Peter Liljeström, Giuseppe Pantaleo, José Luis Jiménez, Mariano Esteban, Beatriz Perdiguero, Carmen E Gómez, Juan Carlos López Bernaldo de Quirós, Judit Pich, Joan Albert Arnaiz, Josep Maria Gatell, Agathe León
2010-07-01

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques

Anne M Bridgeman, Karl Ljungberg, Peter Liljeström, David A Price, Andrew James McMichael, Cornelis J. M. Melief, Daniel C Douek, Brenna J Hill
2008-01-14

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

Alexandre Harari, Peter Liljeström, Jonathan L. Heeney, Wolfgang Stöhr, Giuseppe Pantaleo, Mariano Esteban, Ralf Wagner, James Tartaglia, Marie-Joelle Frachette, Christiane Moog, Pierre-Alexandre Bart, Tristan J Barber, Jean-Pierre Kraehenbuhl, Babiker M A Abdel-Banat
2008-05-27

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.

Ruth L. Goodall, Alexandre Harari, Jonathan L. Heeney, Jaap Goudsmit, Quentin J Sattentau, Giuseppe Pantaleo, Mariano Esteban, Ralf Wagner, Marie-Joelle Frachette, Peter Liljeström, Pierre-Alexandre Bart, Tristan J Barber, Jean-Pierre Kraehenbuhl, Babiker M A Abdel-Banat
2007-06-01

Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor

Peter Liljeström
2006-10-12

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

Peter Liljeström, Friedemann Weber, Caetano Reis e Sousa
2006-07-01

Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling

Pia Dosenovic, Peter Liljeström
2006-08-01

Viral vectors for malaria vaccine development

Thomas P. Monath, Adrian V. S. Hill, Peter Liljeström, Christian F Ockenhouse
2006-10-16

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.

Carmen E Gómez, Giuseppe Pantaleo, Mariano Esteban, Ralf Wagner, Jose Luis Nájera, Marie-Joelle Frachette, Peter Liljeström
2006-12-06

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C

Jens Wild, Peter Liljeström, Giuseppe Pantaleo, Mariano Esteban, Ralf Wagner, Jose Luis Nájera, Carmen E Gómez, Marie-Joelle Frachette, Linda Kostic
2005-06-01

Reversible acid-induced inactivation of the membrane fusion protein of Semliki Forest virus

Gerald M McInerney, Peter Liljeström, Jan Wilschut, Jolanda M Smit, Barry-Lee Waarts
2005-03-01

MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells

Peter Liljeström
2005-08-10

Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles

Gerald M McInerney, Peter Liljeström
2005-08-01

Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting

Juan José Lasarte, Jonathan L. Heeney, Jean-Luc Berland, Peter Liljeström, Gláucia Paranhos-Baccalà
2005-02-13

Toll-like receptor 3 promotes cross-priming to virus-infected cells

Martijn A. Nolte, Lena Alexopoulou, Caetano Reis e Sousa, Peter Liljeström, Флейвелл, Ричард Энтони
2004-09-01

DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model

Peter Liljeström, Mirja Puolakkainen
2004-08-01

Semliki Forest virus produced in the absence of the 6K protein has an altered spike structure as revealed by decreased membrane fusion capacity

Gerald M McInerney, Peter Liljeström, Jan Wilschut

Human - wd:Q55136644

Добро пожаловать в Inventaire

the library of your friends and communities

узнать больше